Depreciation in USD of Pasithea Therapeutics Corp. from 2021 to Q2 2025

Taxonomy & unit
us-gaap: USD
Description
The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.
Summary
Pasithea Therapeutics Corp. quarterly/annual Depreciation history and growth rate from 2021 to Q2 2025.
  • Pasithea Therapeutics Corp. Depreciation for the quarter ending June 30, 2025 was $4K, a 20% decline year-over-year.
  • Pasithea Therapeutics Corp. annual Depreciation for 2024 was $18.9K, a 3.14% increase from 2023.
  • Pasithea Therapeutics Corp. annual Depreciation for 2023 was $18.3K, a 259% increase from 2022.
  • Pasithea Therapeutics Corp. annual Depreciation for 2022 was $5.09K, a 269% increase from 2021.
Depreciation, Quarterly (USD)
Depreciation, YoY Quarterly Growth (%)
Depreciation, Annual (USD)
Depreciation, YoY Annual Growth (%)

Pasithea Therapeutics Corp. Quarterly Depreciation (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q2 2025 $4K -$1K -20% Apr 1, 2025 Jun 30, 2025 10-Q 2025-08-14
Q1 2025 $4.17K -$551 -11.7% Jan 1, 2025 Mar 31, 2025 10-Q 2025-05-15
Q2 2024 $5K Apr 1, 2024 Jun 30, 2024 10-Q 2025-08-14
Q1 2024 $4.72K +$538 +12.9% Jan 1, 2024 Mar 31, 2024 10-Q 2025-05-15
Q1 2023 $4.18K -$835 -16.7% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-14
Q1 2022 $5.01K Jan 1, 2022 Mar 31, 2022 10-Q 2022-05-16

Pasithea Therapeutics Corp. Annual Depreciation (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed
2024 $18.9K +$575 +3.14% Jan 1, 2024 Dec 31, 2024 10-K 2025-03-24
2023 $18.3K +$13.2K +259% Jan 1, 2023 Dec 31, 2023 10-K 2025-03-24
2022 $5.09K +$3.72K +269% Jan 1, 2022 Dec 31, 2022 10-K 2024-03-29
2021 $1.38K Jan 1, 2021 Dec 31, 2021 10-K 2023-03-30
* An asterisk sign (*) next to the value indicates that the value is likely invalid.